Search Articles — Sudonull

Search Results

In this project

Efficient network simulation: vESR Eltex in GNS3

https://sudonull.com/efficient-network-simulation-vesr-eltex-in-gns3

Detailed guide to integrating the Eltex vESR virtual router with GNS3. Installation, configuration, bypassing restrictions and practical application for testing network solutions.

From other projects

The Matthew Effect in Crypto: Why Early Movers Win

https://ymaho.com/the-matthew-effect-in-crypto-why-early-movers-win

Discover how the Matthew Effect shapes crypto markets, why liquidity compounds, and why waiting for consensus often means missing the biggest shifts.

Dunning-Kruger Effect in Betting: The Beginner's Trap

https://lrivo.com/dunning-kruger-effect-in-betting-the-beginner-s-trap

Why do first wins in betting lead to failure? Learn how the Dunning-Kruger effect destroys your bankroll and get a checklist for protection. Start objective analysis now!

Digital detox: anti-age effect in 48 hours

https://ymaho.com/digital-detox-anti-age-effect-in-48-hours

How giving up gadgets on weekends reduces cortisol and slows skin aging. Clinical data and practical conclusions. Try detox this weekend!

Art Slows Aging: 4% Effect According to DunedinPACE

https://ymaho.com/art-slows-aging-4-effect-according-to-dunedinpace

Epigenetic study by UCL proved: regular engagement with art slows biological aging by 4%, just like sports. Find out which practices work.

MitoQ: study of its effect on aging — a new standard?

https://ymaho.com/mitoq-study-of-its-effect-on-aging-a-new-standard

Analysis of the clinical study of the antioxidant MitoQ and the epigenetic clock LinAge3: who benefits from the race for biological rejuvenation and what are the hidden risks. Learn the details.

Robotic hepatectomy: efficacy and marketing

https://ymaho.com/robotic-hepatectomy-efficacy-and-marketing

Analysis of a publication on 2600 robotic liver surgeries. Real data, hidden manipulations, and forecasts for MedTech. Read the details.

Survodutide in obesity: 13% efficacy in phase 3

https://ymaho.com/survodutide-in-obesity-13-efficacy-in-phase-3

The new dual agonist Survodutide showed 13% weight reduction in patients with obesity without diabetes. Learn about the mechanism of action, side effects, and prospects of the drug.

Trending Now